L. Piñeiro

A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C.

E. Solsona, S. Isorna, R. Madero, 2007, European urology.

HIV-associated respiratory disease

L. Piñeiro, M. Nunez, 1996, The Lancet.

intravascular leiomyomatosis a case report and review of the literature

Á. F. Heredero, L. Piñeiro, L. R. D. Moral, 2019 .